Chapter 1. RENAL BIOMARKERS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. RENAL BIOMARKERS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. RENAL BIOMARKERS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. RENAL BIOMARKERS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. RENAL BIOMARKERS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. RENAL BIOMARKERS MARKET - By Biomarker Type

6.1. Functional Biomarker

6.2. Serum Creatinine

6.3. Serum Cystatin C

6.4. Urine Albumin

6.5. Up-regulated Protein

6.6. Neutrophil Gelatinase-Associated Lipocalin (NGAL)

6.7. Kidney Injury Molecule-1

6.8. INTERLEUKIN-18

6.9. Others

Chapter 7. RENAL BIOMARKERS MARKET - By Diagnostic Technique

7.1. Enzyme-linked Immunosorbent Assay (ELISA)

7.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)

7.3. Colorimetric Assay

7.4. Chemiluminescent Enzyme Immunoassay (CLIA)

7.5. Liquid Chromatography Mass Spectrometry (LC-MS)

Chapter 8. RENAL BIOMARKERS MARKET - By End-user

8.1. Hospital

8.2. Diagnostic Laboratory

8.3. Others

Chapter 9. RENAL BIOMARKERS MARKET – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. RENAL BIOMARKERS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10